关于在晚期帕金森病中启动和维持福斯莱沃多巴/福斯卡比多巴的考虑因素
K Ray Chaudhuri1,2,3, Bruno Bergmans4,5, Eric Freire-Alvarez6,7
1PDNMG, King's College Hospital London, Dubai, United Arab Emirates.
Movement disorders clinical practice
|January 16, 2026
概括
利沃多巴/糖比多巴 (LDp/CDp) 连续输液可改善晚期帕金森病 (PD) 的运动控制. 实践指南涵盖了患者选择,启动和管理,以便在现实世界中成功使用.
科学领域:
- 神经学 神经学
- 药理学 药理学是指药理学的学科.
- 医疗器械 医疗器械
背景情况:
- 晚期帕金森病 (PD) 在使用口服药物来控制运动波动方面存在挑战.
- 持续的皮下输注利多巴/利卡比多巴 (LDp/CDp) 提供稳定的利多巴水平,减轻运动波动.
- 自从其上市以来,LDp/CDp已经获得了重要的临床应用.
研究的目的:
- 提供关于LDp/CDp在晚期PD的实际应用的实用临床指导.
- 详细介绍患者选择,治疗开始,剂量调整和LDp/CDp治疗的长期管理策略.
- 为解决临床医生在LDp/CDp上管理患者所面临的关键问题.
主要方法:
- 一个叙述性回顾,结合LDp/CDp研究中的研究者经验.
- 包括具有使用LDp/CDp的实际实践经验的临床医生的见解.
- 专注于解决LDp/CDp治疗的临床关键问题.
主要成果:
- 持续24小时的LDp/CDp输液确保了持续的症状控制,改善了运动波动和生活质量.
- 可以在门诊机构启动和有效管理LDp/CDp治疗,避免住院治疗.
- 输液部位事件很常见,但通常是轻度至中度的,可以通过早期干预来控制;系统性不良事件可能需要调整输液速率.
结论:
- 利多巴/糖多巴 (LDp/CDp) 是一种有价值的新疗法,用于晚期帕金森病.
- 成功的LDp/CDp治疗取决于患者教育,适当的选择,预期管理,个性化的剂量和积极的不良影响管理.
相关概念视频
Parkinson's Disease: Treatment
987
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
987
Parkinson's Disease: Overview
1.8K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
1.8K
Drug Administration and Therapy Phases: Overview
1.3K
Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
1.3K
Determination of Multiple Dosing Parameters: Loading and Maintenance Doses
222
A loading dose is an essential pharmacological strategy to rapidly achieve the target plasma drug concentration necessary for an immediate therapeutic effect. This approach is especially critical for drugs characterized by slow absorption or extended half-lives, where delaying therapeutic plasma levels could compromise treatment outcomes. By administering a loading dose, clinicians ensure a prompt onset of drug action, even for agents with complex pharmacokinetic profiles.Achieving steady-state...
222
Drug Dosing: Geriatric Patients
228
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
228
Rational Dosage Regimen: Maintenance Dose and Loading Dose
5.4K
A rational dosage regimen considers a drug's pharmacokinetics, including its absorption, distribution, metabolism, and elimination from the body. By understanding these factors, the appropriate dosage can be determined, and the dosing schedule can be designed to achieve and maintain the desired therapeutic effect while minimizing adverse effects.
In most cases, drugs are administered repetitively or infused continuously to maintain a steady-state concentration in the body. At a steady...
In most cases, drugs are administered repetitively or infused continuously to maintain a steady-state concentration in the body. At a steady...
5.4K


